The National COVID Task Force has asked states to prioritise young patients for giving antifungal drug Amphotericin B for treatment of Mucormycosis, also known as Black fungus. The Task Force has identified Mucormycosis as a public health concern. "Management of mucormycosis should start with surgical debridement leaving clean margins, control of blood sugar levels," an advisory by the task force said.
